Methods and systems for presenting a combination treatment

• US 20090270688A1
• Filed: 10/28/2008
• Published: 10/29/2009
• Est. Priority Date: 04/24/2008
• Status: Abandoned Application

• Current Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Original Assignee: Searete LLC (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Lord, Robert W., Levien, Royce A., Wood, Lowell L. JR., Hyde, Roderick A., Malamud, Mark A., Sweeney, Elizabeth A., Wood, Victoria Y.H., Leuthardt, Eric C.
• Application Number:
  US12/290,227
• Publication Number:
  US 20090270688A1
• Time in Patent Office: Days
• US Class Current: 600/300
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 20/70 relating to mental therapies, e.g. psychological therapy or autogenous training
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems

Abstract

Methods, computer program products, and systems are described that include accepting an indication of an individual'"'"'s compliance with an artificial sensory experience and presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience.

Claims

1. A computer-implemented method, comprising:

accepting an indication of an individual'"'"'s compliance with an artificial sensory experience; and

presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience.

2-31. -31. (canceled)

32. A system, comprising:

means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience; and

means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience.

33. The computer-implemented method of claim 32, wherein the means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience comprises:

means for accepting an indication of an individual'"'"'s compliance with at least one artificial sensory experience prescribed for the individual.

34. The computer-implemented method of claim 32, wherein the means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience comprises:

means for accepting a report of self compliance by the individual.

35. The computer-implemented method of claim 32, wherein the means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience comprises:

means for accepting a report of the individual'"'"'s compliance from a health care provider.

36. The computer-implemented method of claim 32, wherein the means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience comprises:

means for accepting a report of the individual'"'"'s compliance from an artificial sensory experience provider.

37. The computer-implemented method of claim 32, wherein the means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience comprises:

means for accepting an indication of artificial sensory experience usage by the individual.

38. The computer-implemented method of claim 37, wherein the means for accepting an indication of artificial sensory experience usage by the individual comprises:

means for accepting an indication of computer usage.

40. The computer-implemented method of claim 37, wherein the means for accepting an indication of artificial sensory experience usage by the individual comprises:

means for accepting an indication of interactive device usage.

41. The computer-implemented method of claim 32, wherein the means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience comprises:

means for accepting an output from a presence detector.

43. The computer-implemented method of claim 32, wherein the means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience comprises:

means for accepting an indication of a physiological measurement.

44. The computer-implemented method of claim 43, wherein the means for accepting an indication of a physiological measurement comprises:

means for accepting an indication of at least one of a respiratory rate, body weight, body mass index number, heart rate, blood oxygen level, or blood pressure proximate to administration of the bioactive agent.

45. The computer-implemented method of claim 43, wherein the means for accepting an indication of a physiological measurement comprises:

means for continuously monitoring a parameter of a physiological measurement.

46. The computer-implemented method of claim 43, wherein the means for accepting an indication of a physiological measurement comprises:

means for accepting an indication of a current parameter value compared with an expected parameter value.

47. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for presenting an identification of a prescribed bioactive agent.

48. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for presenting at least one effect of the bioactive agent in near real time.

49. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for indicating at least one side effect of the bioactive agent.

50. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for utilizing an algorithm configured for recommending the bioactive agent.

53. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for indicating at least one of a recommended bioactive agent dosage or a recommended bioactive agent delivery method.

54. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for utilizing an algorithm configured for matching at least one detected physiologic attribute of the individual with a prescription medication at a time proximate to the individual'"'"'s use of the artificial sensory experience.

55. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for determining a compatibility between the artificial sensory experience and the bioactive agent using at least one of a medical history, experimental data, or a medical reference book.

56. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for presenting the indication to at least one output device.

57. The computer-implemented method of claim 56, wherein the means for presenting the indication to at least one output device comprises:

means for presenting the indication to at least one user interface.

58. The computer-implemented method of claim 56, wherein the means for presenting the indication to at least one output device comprises:

means for presenting the indication to at least one mobile device.

59. The computer-implemented method of claim 32, wherein means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for presenting the indication to a third party.

62. The computer-implemented method of claim 32, wherein means for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience and means for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience comprises:

means for accepting a self report by an individual of compliance with a prescription for a virtual world configured to reduce depression and presenting a prescribed dosage for an antidepressant medication at least partly based on the self report.

39. (canceled)

42. (canceled)

51. (canceled)

52. (canceled)

60. (canceled)

61. (canceled)

63. A system, comprising:

circuitry for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience; and

circuitry for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience.

64. A computer program product comprising:

a signal-bearing medium bearing

one or more instructions for accepting an indication of an individual'"'"'s compliance with an artificial sensory experience; and

one or more instructions for presenting an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience.

65. The computer program product of claim 64, wherein the signal-bearing medium includes a computer-readable medium.

66. The computer program product of claim 64, wherein the signal-bearing medium includes a recordable medium.

67. The computer program product of claim 64, wherein the signal-bearing medium includes a communications medium.

68. A system comprising:

a computing device; and

instructions that when executed on the computing device cause the computing device to

accept an indication of an individual'"'"'s compliance with an artificial sensory experience; and

present an indication of a bioactive agent at least partly based on the indication of the individual'"'"'s compliance with the artificial sensory experience.

69. The system of claim 68 wherein the computing device comprises:

one or more of a personal digital assistant (PDA), a personal entertainment device, a mobile phone, a laptop computer, a tablet personal computer, a networked computer, a computing system comprised of a cluster of processors, a computing system comprised of a cluster of servers, a workstation computer, and/or a desktop computer.

70. The system of claim 68, wherein the computing device is operable to accept the at least one attribute of the at least one individual and present the indication of the at least one prescription medication and the at least one artificial sensory experience from at least one memory.